Revive Formulations India Private Limited, a active private limited company, was established on 06 March 2015 in Vanur Taluk, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U36900TN2015PTC099527. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 43 professional, Its leadership includes Sakthidaran Swamirajan (Additional Director), Ramakesu Appasamy Pillai (Additional Director), Chakravarthy Murugan (Director). Past directors included Kailasa Mudaliar Koumaravelou. It holds ₹4.29 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New Rs No.76/3, Old Rs No.122/2-2.76, Plot No.1,2 &3, Perumal Nagar, Aghasampa, Ttu Villag, Vanur Taluk, Tamil Nadu, 605109.
U36900TN2015PTC099527
099527
06 March 2015
₹0.10 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Revive Formulations India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sakthidaran Swamirajan | Additional Director | 28 Jan 2016 | Current |
| Ramakesu Appasamy Pillai | Additional Director | 09 Apr 2015 | Current |
| Chakravarthy Murugan | Director | 06 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jul 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Revive Formulations India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.77% increase. The company also saw a slight decrease in profitability, with a 6.06% decrease in profit. The company's net worth Soared by an impressive increase of 34.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Revive Formulations India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹42,860,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Sidbi | ₹1.00 Cr | Open |
| 07 Jun 2021 | Sidbi | ₹8.86 M | Open |
| 06 Jun 2020 | Indian Bank | ₹4.50 M | Open |
| 25 Jan 2017 | Indian Bank | ₹2.00 M | Open |
| 29 Dec 2015 | Indian Bank | ₹1.75 Cr | Open |
Explore comprehensive loan charge details -
Revive Formulations India has a workforce of 43 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Revive Formulations India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revive Formulations India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Indian Bank of Rs. 17.50 M registered on 29 Dec 2015 with Charge ID 10616564 was modified on 21 Oct 2024. was completed.
Progress on Revive Formulations India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Revive Formulations India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Progress on A charge with Sidbi amounted to Rs. 10.00 M with Charge ID 100902146 was registered on 30 Mar 2024. was documented.
The activity A charge with Sidbi amounted to Rs. 8.86 M with Charge ID 100450937 was registered on 07 Jun 2021. was completed.
A charge with Indian Bank amounted to Rs. 4.50 M with Charge ID 100345577 was registered on 06 Jun 2020. was recorded as a recent event.
The CIN of Revive Formulations India Private Limited is U36900TN2015PTC099527.
Revive Formulations India Private Limited is headquartered at New Rs No.76/3, Old Rs No.122/2-2.76, Plot No.1,2 &3, Perumal Nagar, Aghasampa, Ttu Villag, Vanur Taluk, Tamil Nadu, 605109.
Revive Formulations India Private Limited was incorporated on 06 March 2015.
The current directors of Revive Formulations India Private Limited are
The primary industry of Revive Formulations India Private Limited is Manufacturing.
Revive Formulations India Private Limited is unlisted.
The authorized capital of Revive Formulations India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Revive Formulations India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX